CD4 and COVID-19: In addition, immune evaluation of two SOTRs a few weeks before second infection showed that they had virus-specific CD4+ T cell responses and positive IgG titers before the second infection, which indicated that the risk of secondary infection was still high for SOTRs previously infected with COVID-19, even after generating cellular and humoral immune responses.